NCT01092442View on ClinicalTrials.gov

CryoValve SG Pulmonary Human Heart Valve Post Clearance Study

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Pulmonary Valve StenosisPulmonary Valve InsufficiencyAortic Valve StenosisAortic Valve Insufficiency
Interventions
PROCEDURE

Echocardiogram

Patients will have a yearly echocardiogram after enrollment in the study.

Trial Locations (8)

46202

Indiana University, Indianapolis

48109

University of Michigan, Ann Arbor

53201

Children's Hospital of Wisconsin, Milwaukee

63110

Washington University, St Louis

73126

Oklahoma University Health and Sciences Center, Oklahoma City

78229

Methodist Healthcare System of San Antonio, San Antonio

78756

Cardiothoracic and Vascular Surgeons and Austin Heart, Austin

85006

Arizona Pediatric Cardiology Consultants, Phoenix

Sponsors

Lead Sponsor

CryoLife, Inc.
All Listed Sponsors
lead

CryoLife, Inc.

INDUSTRY

NCT01092442 - CryoValve SG Pulmonary Human Heart Valve Post Clearance Study | Biotech Hunter | Biotech Hunter